Experience with cyclosporine in pediatric renal transplantation

I E Willetts1, R S Trompeter

  • 1Nephrourology Unit, Great Ormond Street Hospital for Children NHS Trust, London, UK.

Insights

Cyclosporine (CsA) is crucial for pediatric renal transplants but causes side effects. Monitoring drug levels optimizes outcomes and manages adverse events in children receiving kidney transplants.

Area of Science:

  • Pediatric Nephrology
  • Transplantation Immunology

Background:

  • Renal transplantation is established for pediatric end-stage renal disease.
  • Cyclosporine (CsA) became a cornerstone immunosuppressant in the 1980s.
  • CsA is vital for preventing rejection in pediatric kidney recipients.

Purpose of the Study:

  • To explore the role of Cyclosporine (CsA) in pediatric renal transplantation.
  • To highlight the importance of managing CsA's adverse effects.
  • To emphasize therapeutic drug monitoring for optimal outcomes.

Main Methods:

  • Review of clinical immunosuppressive protocols involving CsA.
  • Analysis of adverse effects associated with CsA therapy.
  • Discussion of therapeutic drug level monitoring strategies.

Main Results:

  • CsA has been central to successful pediatric renal transplant protocols.
  • Adverse effects include hypertension, hyperlipidemia, nephrotoxicity, hirsutism, and gum hyperplasia.
  • Cosmetic side effects significantly impact pediatric patient compliance.

Conclusions:

  • CsA remains critical in pediatric renal transplantation.
  • Careful monitoring and management of side effects are essential.
  • Therapeutic drug level monitoring is key to optimizing clinical outcomes and ensuring graft survival.

Related Concept Videos

Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...